<!-- wp:paragraph -->
<p><strong>"SCANDENS
PHARMACEUTİCAL İNDUSTRİES Ltd"</strong> - the first
pharmaceutical plant for the complete production cycle of Pharmaceutical
formulations in Azerbaijan was established in 2016. Construction of the plant
started in 2017.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
first stage of production involves solid medicines forms including tablets,
capsules and granules over the full production cycle from granulation to
finished products and batch release from its own Quality Control laboratory as
well as its high standard Quality system.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The second stage will be for Manufacturing and release
of ointments and suppositories.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The third stage is targeted to the sterilized products
- ampoules for injection and infusion solutions.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; "Scandens
Pharmaceuticals İndustries Ltd" offers large cooperation opportunities
with other pharmaceutical companies in the areas of producers of manufacturing
based on technology transfer, licensed production, and contract production.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The plant is designed by one of the leading consulting companies engaged in the pharmaceutical field who has more than 400 pharmaceutical successfully operating plants into their credit in various countries across the globe.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p> Plant current designed &nbsp;production capacity in the first stage is 600 million tablets and 150 million capsules, which will provide the need for tablet and capsule medicine forms of many therapeutic  groups, such as cardiology, antidiabetic, anti-tuberculosis, analgesic, anti-inflammatory and others. More than 100 generic formulations are being planned to produce.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph {"fontSize":"medium"} -->
<p class="has-medium-font-size"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; “Scandens Pharmaceutical Industries Ltd.”</strong> has the following strategic opportunities&nbsp; &nbsp;for entering the Azerbaijan and surrounding pharmaceutical market: </p>
<!-- /wp:paragraph -->

<!-- wp:list -->
<ul><li>Being a local manufacturing company <strong>Scandens</strong> offer a low inventory and lower cost product of international standard for the Institutional and government purchasing programs.<ul><li><strong>Scandens</strong> can offer low volume products due to its versatile production capacity which is difficult to import due to large MOQ (Minimal Order Quantity) for market from the international vendors.</li><li><strong>Scandens</strong> can manufacture new high technology products with a minimum possible quantity for launch and further development.</li><li><strong>Scandens</strong> can produce pharmaceutical products in cooperation with other pharmaceutical companies.<ul><li>Due to the presence of full technological production cycle, Manufacturing with transfer of technology.</li><li>Contract manufacturing of products on “<strong>Scandens</strong>” facilities.</li><li>Production of “<strong>Scandens</strong>” trade marks in other manufacturing facilities in bulk and doing the partial production and batch release at local site.</li></ul></li></ul></li><li><strong>Scandens</strong> can manufacture bulk tablets or capsules and export to other companies.<ul><li><strong>Scandens</strong> can manufacture products of large companies under license.</li></ul><ul><li>Blisters packaging and inserting leaflets on the local language into packages can also be offered as a business opportunity by <strong>Scandens.</strong></li></ul><ul><li>Possibility of entering to other pharmaceutical markets:<ul><li>Having good commercial relation with Uzbekistan, Kazakhstan, Turkmenistan, Tajikistan, Kirgizstan, Russia Federation and Iran also, will help large multinational companies to enter these markets with minimum primary volumes from “<strong>Scandens</strong>”.</li></ul></li></ul></li></ul>
<!-- /wp:list -->

<!-- wp:paragraph -->
<p>Our <strong>vision</strong> is to provide high-quality products to meet customers’ expectations, and to bring the technology of Pharmaceutical manufacturing to Azerbaijan thus creating an organization wherein people will be inspired, interested and motivated, and creating opportunities for their fully use of talent and energy.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p></p>
<!-- /wp:paragraph -->